Advent France Biotechnology has held an €86m first close for its second fund, already surpassing the size of its debut vehicle in the strategy. The post Advent France Biotechnology holds €86m first close for Fund
Italian life sciences investor Panakès Partners has hired Rob Woodman as partner to lead the firm’s newly created biotech investment team. The post Italy’s Panakès Partners hires industry veteran Rob Woodman to lead new biotech
Early-stage European biopharma investment specialist BioGeneration Ventures has named Keno Gutierrez as a partner and Wouter Verhoeven as a venture partner. The post BGV hires veteran pair to boost life science investment expertise first appeared on
US private equity major GTCR's Antylia Scientific portfolio company has agreed to sell its Masterflex business unit to Avantor for $2.9bn in an all-cash transaction. The post GTCR to sell Antylia Scientific’s Masterflex unit in
Thompson Street Capital Partners has bought Vector Laboratories, the protein detection business unit of Nasdaq-listed Maravai. The post Thompson Street Capital carves out Vector Labs from Nasdaq-listed Maravai first appeared on AltAssets Private Equity News.
Buyout giant Bain Capital has raised $1.9bn for its second life sciences-focused fund targeting pharma and biopharma, medical device and diagnostics deals. The post Bain Capital continues 2021 fundraising streak with hefty $1.9bn life science
Sands Capital has held a first and final closing of its second life sciences dedicated fund on $560m, leading the total asset under management in the firm’s Pulse Strategy to more than $950m. The post
Italian life sciences investor Panakès Partners has struck a €150m first close for its sophomore fundraise amid upping its goal to €180m and expanding into biotech. The post Panakès Partners hits €150m first close for
Life science investor Abingworth has upped the ante yet again with its 13th fundraise by hitting a $465m final close for the fund.
UK buyout house Montagu Private Equity has entered exclusive negotiations with Qualium Investissement and management to acquire IMV Technologies.
Google's Alphabet stablemate Verily has picked up a roughly $1bn investment round led by private equity house Silver Lake as it looks to expands its life sciences research and engineering capabilities.
European life science venture capital firm Forbion has sealed its fastest fundraise to date after hitting the €460m hard cap for its latest investment vehicle in just a few weeks.
Irish life sciences investment major Fountain Healthcare Partners has brought its funds under management to €300m through the target-beating final close of its third fundraise.
Blackstone has scored a hefty return by agreeing the $14.6bn sale of US life science office buildings major BioMed Realty.
Life science-focused RiverVest Venture Partners is out eyeing up to $200m for its fifth fundraise.
Life sciences investor Catalio Capital Management has hit the $100m hard cap for its second venture capital fundraise.
Arsenal Capital Partners has named life sciences veteran Dr Richard Eglen as a senior advisor to its healthcare team.
European life sciences investor Medicxi has hit a €200m final close for its debut secondaries fund amid using the vehicle to pick up six companies from one of the firm's previous funds.
French investment house Andera Partners is reportedly out targeting up to €450m for its biggest-ever fund, hot on the heels of closing a €500m-plus mezzanine fund in June.
Europe's Advent Life Sciences has sealed a sale of KaNDy Therapeutics Ltd to industry giant Bayer in a deal which could see it collect in excess of $975m.
